Clinical trial
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With…
NCT00227734 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00227734 |
|---|---|
| Title | Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery |
| Official title | Capecitabine and Oxaliplatin Alone or in Combination With Cetuximab as First-Line Treatment for Metastatic EGFR-Positive Colorectal Cancer, A Randomized Multicenter Phase II Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | capecitabine and oxaliplatin + cetuximab, capecitabine and oxaliplatin |
| Enrollment | 74 |
| Start date | Jun 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Sep 28, 2005 |
| Last update posted | Jun 5, 2012 |
| Countries | Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: